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As the prognosis improves an increasing number of young people with CF enter
adulthood via specialist transition clinics which facilitate the change from child-
centred to adult-orientated care. We reviewed the current characteristics of these
patients and the challenges in providing their care.
Since 2006, 44 young adults (29 men) have attended our transition clinic at a mean
age of 16.6 (range 15–18.5) years. Most were keen to move quickly on to the adult
service, staying in transition for a mean of 5.6 months (range 1−27 months) and
moving to the adult clinic at a mean age of 17 (range 15.8–18.7) years. 38 (86%) had
chronic and 5 (11%) transient pseudomonas infection; 7 (16%) had non-tuberculous
mycobacteria; 3 (7%) had burkholderia organisms and 1 (2%) MRSA. Mean FEV1
was 2.9 L (84%), range 0.5 L (17%) to 5.24 L (129%); mean body mass index was
21 kg/m2 (range 17.7–29.7); 9 (20%) had aspergillosis; 7 (16%) had diabetes;
5 (11%) had gastrostomies; 1 (2%) was on home ventilation; one had had lung
transplantation and one had had liver transplantation; 22 (50%) had moderate/
severe bronchiectasis on x-ray; one smoked cigarettes and two used illegal drugs.
2 men (7%) were unaware of infertility. Speciﬁc challenges early after transfer
included deteriorating respiratory health, moving out of home to university, travel
abroad for a “gap year”, unemployment, and sexual health issues.
Most young adults with CF are keen to move on to adult care and transition issues
continue into the adult clinic. They have a wide spectrum of disease severity but
many have substantial lung disease requiring a high level of care.
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Introduction: A pneumothorax is a serious complication of cystic ﬁbrosis. Pre-
vious work has demonstrated the relationship between pneumothoraces and lung
function, microbiology and other CF complications such as ABPA and pancre-
atic insufﬁciency. Previous evidence has shown anorexia nervosa sufferers can
develop emphysematous changes in their lungs and have a higher prevalence of
pneumothorax. This study examines the relationship between BMI and occurrence
of pneumothorax in a single adult CF centre.
Methods: A retrospective case notes review of all patients experiencing a pneu-
mothorax between 1996 and 2009 was undertaken. Patients were compared to case
controls matched by age, lung function and microbiology.
Results: 74 patients experienced a pneumothorax in the time period. Average age
at ﬁrst pneumothorax was 24.6 years. The mean BMI of patients with a pneu-
mothorax was signiﬁcantly lower than matched controls (18.6±2.4, vs 20.1±3.0
p 0.005). There was no difference in lung function between groups (FEV1%pred,
32.8±13.3 vs 33.7±12.4 p = 0.68). There was no relationship between BMI and the
number of pneumothoraces occurring in each patient.
Conclusions: Low BMI is an independent risk factor for the development of a
pneumothorax in cystic ﬁbrosis patients. Patients experiencing a pneumothorax are
predominantly those with severe lung disease as demonstrated by their spirometry.
Further work needs to be undertaken to elucidate whether emphysematous changes
related to nutrition play a role in the development of pneumothoraces in CF patients
and whether improving BMI decreases the risk of a further pneumothorax.
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Aim: To explore the correlation between VO2 on kinetics during submaximal CPET
and disease severity as it is expressed by Forced Expiratory Volume in 1st second
(FEV1) and Shwachman Score (SS).
Patients and Methods: Fourteen adult patients with CF (8 males, 6 females,
age 22±5 y) underwent pulmonary functional tests during the baseline and sub-
maximal CPET. Forced vital capacity (FVC) and FEV1 measured in the sitting
position, before exercise were used to assess lung function. Submaximal CPET
was performed in a cycloergometer with constant workload rate of 30watt limited
to the sub-anaerobic threshold range. VO2 response (below anaerobic threshold)
is best described by a three-phase model. The ton expresses time needed for the
oxygen consumption to reach 66% of the oxygen consumption at steady state of
submaximal exercise. Shwachman Score (SS) was estimated based on physical
activity and examination, nutrirtional status and Xray ﬁndings.
Results: There was a signiﬁcant negative correlation between FEV1(pred),
FVC(pred), SS and ton (r = −0.8, p = 0.001), (r = −0.8, p = 0.000) and (r = −0.78,
p = 0.001) respectively.
Conclusion: The ﬁnding that there is a signiﬁcant negative correlation between
disease severity and ton it is interesting and needs further investigation as would
identify patients with limited exercise performance due to disease severity.
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The major cause of clinical deterioration and thereby mortality in cystic ﬁbrosis
(CF) is the progressive decline in pulmonary function due to chronic infection,
and an appreciation by the patient of any change in their clinical condition may
facilitate early presentation and treatment and improve the prognosis. However,
there have been no studies predicting patients’ ability to sense changes in their
pulmonary function which might highlight the need for further therapy. We therefore
compared this with spirometry (FEV1), a validated objective measure of pulmonary
function, in a group of 70 consecutive CF patients (mean age 26 [range 17−41],
mean FEV1 59% predicted [23–106]; 39 males) attending our outpatient service.
The appreciation of any change in lung function was made using a bipolar Visual
Analogue Scale (range much worse [-5] to much better [+5]) and this was correlated
with the change in FEV1 (expressed as a % change) from their previous clinic
appointment.
Although there was a signiﬁcant correlation between the patients appreciation
of, and the objective change in, their lung function (r = 0.545, p< 0.001), the
appreciated change differed from the objective change by more than 1 standard
deviation (SD) in 43 (55%) and 2 SD in 26 (37%) patients.
Thus, this study has shown that a large proportion of CF patients are unable to
accurately predict changes in their lung function, reinforcing that routine spirometric
measurement in the outpatient setting is essential to ensure optimum monitoring
and treatment for this group of patients.
